News
3 Stocks Wrongfully Punished For Raising Guidance
Raising guidance usually catalyzes a rally, but for Rivian (NASDAQ: RIVN), Ford (NYSE: F), and Keurig Dr Pepper (NASDAQ: KDP), it didn’t happen this time. However, the takeaway from the moves is
Will Cloudflare See Sunny Skies On Continued Revenue Growth?
Cloudflare Inc. (NYSE: NET) shares are up only fractionally since the company's second-quarter report on August 3, after it's been the subject of conflicting analyst calls.
Revenue grew 32%
Weltgrößte Kobalt-Mine - Autoriese Stellantis (STLA) steigt ein. Börsenstar setzt nach 13.150% mit Vulcan Energy ($VUL) auf diesen Kobalt Hot Stock. Jetzt 355% mit Kobalt Aktientip 2023 Kuniko Ltd. (ISIN: AU0000159840, WKN: A3CTAL, Ticker: 912, ASX:
Weltgrößte Kobalt-Mine - Autoriese Stellantis steigt ein. Börsenstar setzt nach 13.150% auf diesen Kobalt Hot Stock
14.08.23 08:47
Perth, WA (www.aktiencheck.de , Anzeige)
Kinder Morgan Shines With Dividend Yield, Cash Flow, Buybacks
Shares of oil-and-gas infrastructure specialist Kinder Morgan Inc. (NYSE: KMI) are consolidating below a potential buy point north of $20.20.
The stock got an initial boost after its
More Good News Coming? GoodRx Spikes Ahead of Q2 Earnings
When GoodRx Holdings, Inc. (NASDAQ:GDRX) burst onto the scene in the middle of the pandemic, it brought promises of saving Americans money on their drug prescriptions. While consumers have indeed
Citigroup, Wells Fargo, PNC: Undervalued Dividend Growers
If you’re exploring dividend stocks, you can adopt various strategies. You might seek out high-yield stocks, or those with consistent payouts and robust financial conditions, or companies with a
Banking Bulls: 2 Stocks Set To Breakout
The financial sector has steadily firmed over recent months, as the Financial Select Sector SPDR Fund (NYSE: XLF) has climbed over 11% in three months after finding support near a critical level
Europe's Largest Bank Raises Full-Year Guidance, Boosts Dividend
Europe’s largest bank fell along with the broader global market on August 2, despite reporting strong year-over-year revenue and earnings growth the day before.
New Leaders Emerge: S&P 500 Shows Shift in Top Performers
It wasn’t that long ago that the “Magnificent 7” stocks, Apple Inc. (NASDAQ: AAPL), Microsoft Corp. (NASDAQ: MSFT), Nvidia Corp. (NASDAQ: NVDA), Tesla Inc. (NASDAQ: TSLA), Amazon.com Inc. (NASDAQ:
Is Avis Budget Group A Value Play? Earnings Have This To Say
Avis Budget Group (NASDAQ: CAR) stock has been trading within a relatively tight channel for the past year; this can be taken as a sign of indecision from markets facing a directionless market
Hong Kong Financial Firm Futu Surges 33.12% Amid Stimulus Hints
It’s often the case that smaller, arcane stocks can be among the winners in a portfolio. Hong Kong-based Futu Holdings Limited (NASDAQ: FUTU) is a financial technology company providing online
Kimberly-Clark Raises Sales and Profit Guidance, Can it Breakout?
In May 2023, Kimberly-Clark Corporation (NYSE: KMB) stock climbed to a 52-week high of $147.87. However, the stock has failed to hold those gains and heading into the company’s earnings report, KMB
Rivian: A Roaring Rise Or Time To Cash Out?
Since breaking out over critical resistance at $16, shares of Rivian Automotive (NASDAQ: RIVN) haven’t looked back. The stock is up almost 87% in the last month and 106% over the previous three
EMX Options Its Flåt and Bamble Nickel Projects in Norway
Vancouver, British Columbia, July 24, 2023 (NYSE American: EMX; TSX Venture: EMX; Frankfurt: 6E9) – EMX Royalty Corporation (the “Company” or “EMX”) is pleased to announce the execution of
Profits Decline At Goldman Sachs, Time To Pick Up Cheap Shares?
Most investors may be disappointed that the mystical firm, The Goldman Sachs Group (NYSE: GS), a name often synonymous with the creme de la creme on Wall Street, has reported declining business
Morgan Stanley Second Quarter Earnings, Time For A Breakout?
As measured by the VIX (CBOE Volatility Index), volatility in broader equity markets has compressed significantly over the past year. 2022 saw an average VIX above 25%, historically high and
Banking On Bank Of America In The 2nd Half
Results from banks like Bank of America (NYSE: BAC) and JPMorgan Chase (NYSE: JPM) suggest the Fed is getting closer to achieving its much-desired soft-landing. Bank of America’s Q2 results are
How the NASDAQ 100 Special Rebalancing Will Hurt Performance
On July 7, 2023, the Nasdaq announced it would implement a special rebalancing for the Nasdaq 100 index, tracked by the Invesco QQQ ETF (NASDAQ: QQQ) effective after hours on July 21, 2023, and
Wells Fargo's Earnings, Why Markets Are Loving The Stock
The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) has been trading within a tight channel during the past year, hovering between the $420 and $375 per share marks. This trading range could be seen as
Citigroup Leads Banking Earnings, What's Next?
Not too long ago, commercial and investment banks passed the annual FED 'stress test,' where banks are under the heat of liquidity and leverage scrutiny. The leading United States firms passed
BlackRock Kicks Off Financials Earnings Season, Gauge To Markets
A new earnings season is beginning to kick off, bringing on periods of increased volatility and opportunity to investors as long as they position themselves within the favored industries and names
JPMorgan Chase Is In Reversal But Don’t Chase It Higher
The price action in JPMorgan Chase & Company (NYSE: JPM) has been bullish all year. The prospect of higher interest rates, widening margins, and increased earnings have helped to drive the market
Analysts Are Recommending Symbiotic In July, High Potential?
Every market turn, such as the one investors encounter today, brings to light a set of favorite industries with their own set of perceived 'winning' stocks. The larger the underlying pivot, the
3 Reasons Why Rivian Can Continue To Surge Higher
Just over a week ago, shares of Rivian Automotive (NASDAQ: RIVN) were in the negative year-to-date. When I first wrote about Rivian precisely one week ago, the stock was up just 6.13% YTD. Today
Is BioMarin Ready To Rebound After FDA Approval Of Roctavian?
BioMarin (NASDAQ: BMRN) shares have been under pressure due to delays in approving its hemophilia A drug Roctavian. That is over. The drug, which targets hemophilia A in a 1-time treatment, was